BARD1, AN ONCOGENIC DRIVER AND BIOMARKER OF LUNG CANCER

被引:0
|
作者
Pilyugin, M. [1 ,2 ]
Andre, P. [1 ,2 ]
Laurent, G. [3 ]
Irminger-Finger, I. [1 ,2 ,3 ]
机构
[1] Univ Hosp Geneva, Dept Gynecol Obstet, Mol Gynecol & Obstet Lab, Geneva, Switzerland
[2] Univ Hosp Geneva, Dept Med Genet & Labs, Geneva, Switzerland
[3] Univ Western Australia, Sch Med & Pharmacol, Ctr Cell Therapy & Regenerat Med, Nedlands, WA 6009, Australia
关键词
D O I
10.1111/resp.12263_11
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
引用
收藏
页码:17 / 17
页数:1
相关论文
共 50 条
  • [21] An isoform of BARD1, associated with many types of cancer, is a driver of oncogenesis by inducing telomere aberrations in vitro and in vivo
    Pilyugin, Maxim
    Andre, Pierre-Alain
    Ratajska, Magdalena
    Irminger-Finger, Irmgard
    CANCER RESEARCH, 2015, 75
  • [22] Distinct Roles of BARD1 Isoforms in Mitosis: Full-Length BARD1 Mediates Aurora B Degradation, Cancer-Associated BARD1β Scaffolds Aurora B and BRCA2
    Ryser, Stephan
    Dizin, Eva
    Jefford, Charles Edward
    Delaval, Benedicte
    Gagos, Sarantis
    Christodoulidou, Agni
    Krause, Karl-Heinz
    Birnbaum, Daniel
    Irminger-Finger, Irmgard
    CANCER RESEARCH, 2009, 69 (03) : 1125 - 1134
  • [23] Cancer predisposing BARD1 mutations in breast–ovarian cancer families
    Magdalena Ratajska
    Ewelina Antoszewska
    Anna Piskorz
    Izabela Brozek
    Åke Borg
    Hanna Kusmierek
    Wojciech Biernat
    Janusz Limon
    Breast Cancer Research and Treatment, 2012, 131 : 89 - 97
  • [24] Characterization of novel BARD1 splice variants in colon cancer
    Sporn, Judith C.
    Jung, Barbara H.
    CANCER RESEARCH, 2011, 71
  • [25] BARD1 deletion in a patient with suspected hereditary colorectal cancer
    Takaiso, Nobue
    Imoto, Issei
    Yoshimura, Akiyo
    Ouchi, Akira
    Komori, Koji
    Iwata, Hiroji
    Shimizu, Yasuhiro
    HUMAN GENOME VARIATION, 2024, 11 (01)
  • [26] Bioinformatics Analysis of Expression and Alterations of BARD1 in Breast Cancer
    Chen, Yong-Zi
    Zuo, Duo
    Ren, Hai-Ling
    Fan, Sai-Jun
    Ying, Guoguang
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2019, 18
  • [27] BARD1 mystery: tumor suppressors are cancer susceptibility genes
    Hawsawi, Yousef M.
    Shams, Anwar
    Theyab, Abdulrahman
    Abdali, Wed A.
    Hussien, Nahed A.
    Alatwi, Hanan E.
    Alzahrani, Othman R.
    Oyouni, Atif Abdulwahab A.
    Babalghith, Ahmad O.
    Alreshidi, Mousa
    BMC CANCER, 2022, 22 (01)
  • [28] BARD1 mystery: tumor suppressors are cancer susceptibility genes
    Yousef M. Hawsawi
    Anwar Shams
    Abdulrahman Theyab
    Wed A. Abdali
    Nahed A. Hussien
    Hanan E. Alatwi
    Othman R. Alzahrani
    Atif Abdulwahab A. Oyouni
    Ahmad O. Babalghith
    Mousa Alreshidi
    BMC Cancer, 22
  • [29] Common Variation at BARD1 Results in the Expression of an Oncogenic Isoform That Influences Neuroblastoma Susceptibility and Oncogenicity
    Bosse, Kristopher R.
    Diskin, Sharon J.
    Cole, Kristina A.
    Wood, Andrew C.
    Schnepp, Robert W.
    Norris, Geoffrey
    Nguyen, Le B.
    Jagannathan, Jayanti
    Laquaglia, Michael
    Winter, Cynthia
    Diamond, Maura
    Hou, Cuiping
    Attiyeh, Edward F.
    Mosse, Yael P.
    Pineros, Vanessa
    Dizin, Eva
    Zhang, Yongqiang
    Asgharzadeh, Shahab
    Seeger, Robert C.
    Capasso, Mario
    Pawel, Bruce R.
    Devoto, Marcella
    Hakonarson, Hakon
    Rappaport, Eric F.
    Irminger-Finger, Irmgard
    Maris, John M.
    CANCER RESEARCH, 2012, 72 (08) : 2068 - 2078
  • [30] Cancer predisposing BARD1 mutations in breast-ovarian cancer families
    Ratajska, Magdalena
    Antoszewska, Ewelina
    Piskorz, Anna
    Brozek, Izabela
    Borg, Ake
    Kusmierek, Hanna
    Biernat, Wojciech
    Limon, Janusz
    BREAST CANCER RESEARCH AND TREATMENT, 2012, 131 (01) : 89 - 97